Literature DB >> 12958319

Left ventricular mass and geometry and the risk of ischemic stroke.

Marco R Di Tullio1, Donna R Zwas, Ralph L Sacco, Robert R Sciacca, Shunichi Homma.   

Abstract

BACKGROUND AND
PURPOSE: Left ventricular hypertrophy (LVH) is a risk factor for cardiovascular events, but its effect on ischemic stroke risk is established mainly in whites. The effect of LV geometry on stroke risk has not been defined. The aim of the present study was to evaluate whether LVH and LV geometry are independently associated with increased ischemic stroke risk in a multiethnic population.
METHODS: A population-based case-control study was conducted on 394 patients with first ischemic stroke and 413 age-, sex-, and race-ethnicity-matched community control subjects. LV mass was measured by transthoracic echocardiography. LV geometric patterns (normal, concentric remodeling, concentric or eccentric hypertrophy) were identified. Stroke risk associated with LVH and different LV geometric patterns was assessed by conditional logistic regression analysis in the overall group and age, sex, and race-ethnic strata, with adjustment for established stroke risk factors.
RESULTS: Concentric hypertrophy carried the greatest stroke risk (adjusted odds ratio [OR], 3.5; 95% confidence interval [CI], 2.0 to 6.2), followed by eccentric hypertrophy (adjusted OR, 2.4; 95% CI, 2.0 to 4.3). Concentric remodeling carried slightly increased stroke risk (adjusted OR, 1.7; 95% CI, 1.0 to 2.9). Increased LV relative wall thickness was independently associated with stroke after adjustment for LV mass (OR, 1.6; 95% CI, 1.1 to 2.3).
CONCLUSIONS: LVH and abnormal LV geometry are independently associated with increased stroke risk. LVH is strongly associated with ischemic stroke in all age, sex, and race-ethnic subgroups. Increased LV relative wall thickness imparts an increased stroke risk after adjustment for LV mass and is of additional value in stroke risk prediction.

Entities:  

Mesh:

Year:  2003        PMID: 12958319      PMCID: PMC2812917          DOI: 10.1161/01.STR.0000089680.77236.60

Source DB:  PubMed          Journal:  Stroke        ISSN: 0039-2499            Impact factor:   7.914


  37 in total

1.  Prediction of mortality risk by different methods of indexation for left ventricular mass.

Authors:  Y Liao; R S Cooper; R Durazo-Arvizu; G A Mensah; J K Ghali
Journal:  J Am Coll Cardiol       Date:  1997-03-01       Impact factor: 24.094

2.  Neurohormonal activity and left ventricular geometry in patients with essential arterial hypertension.

Authors:  M W Muscholl; H Schunkert; F Muders; D Elsner; B Kuch; H W Hense; G A Riegger
Journal:  Am Heart J       Date:  1998-01       Impact factor: 4.749

3.  Prognostic significance of serial changes in left ventricular mass in essential hypertension.

Authors:  P Verdecchia; G Schillaci; C Borgioni; A Ciucci; R Gattobigio; I Zampi; G Reboldi; C Porcellati
Journal:  Circulation       Date:  1998 Jan 6-13       Impact factor: 29.690

Review 4.  Why is left ventricular hypertrophy so predictive of morbidity and mortality?

Authors:  E J Benjamin; D Levy
Journal:  Am J Med Sci       Date:  1999-03       Impact factor: 2.378

5.  Left atrial size and the risk of ischemic stroke in an ethnically mixed population.

Authors:  M R Di Tullio; R L Sacco; R R Sciacca; S Homma
Journal:  Stroke       Date:  1999-10       Impact factor: 7.914

6.  Influence of left ventricular geometric patterns on prognosis in patients with or without coronary artery disease.

Authors:  J K Ghali; Y Liao; R S Cooper
Journal:  J Am Coll Cardiol       Date:  1998-06       Impact factor: 24.094

7.  Impact of left ventricular structure on the incidence of hypertension. The Framingham Heart Study.

Authors:  W S Post; M G Larson; D Levy
Journal:  Circulation       Date:  1994-07       Impact factor: 29.690

8.  Association of carotid atherosclerosis and left ventricular hypertrophy.

Authors:  M J Roman; T G Pickering; J E Schwartz; R Pini; R B Devereux
Journal:  J Am Coll Cardiol       Date:  1995-01       Impact factor: 24.094

9.  Prognosis of left ventricular geometric patterns in the Framingham Heart Study.

Authors:  H M Krumholz; M Larson; D Levy
Journal:  J Am Coll Cardiol       Date:  1995-03-15       Impact factor: 24.094

10.  Adverse prognostic significance of concentric remodeling of the left ventricle in hypertensive patients with normal left ventricular mass.

Authors:  P Verdecchia; G Schillaci; C Borgioni; A Ciucci; M Battistelli; C Bartoccini; A Santucci; C Santucci; G Reboldi; C Porcellati
Journal:  J Am Coll Cardiol       Date:  1995-03-15       Impact factor: 24.094

View more
  41 in total

Review 1.  Cardiac remodeling at the population level--risk factors, screening, and outcomes.

Authors:  Ola Gjesdal; David A Bluemke; Joao A Lima
Journal:  Nat Rev Cardiol       Date:  2011-10-25       Impact factor: 32.419

2.  Heritability of left ventricular mass and other morphologic variables in Caribbean Hispanic subjects: the Northern Manhattan Family Study.

Authors:  Suh-Hang Hank Juo; Marco R Di Tullio; Hsiu-Fen Lin; Tanja Rundek; Bernadette Boden-Albala; Shunichi Homma; Ralph L Sacco
Journal:  J Am Coll Cardiol       Date:  2005-08-16       Impact factor: 24.094

Review 3.  Increased prevalence of concentric left ventricular hypertrophy in African-Americans: will an epidemic of heart failure follow?

Authors:  Sandeep Kamath; David Markham; Mark H Drazner
Journal:  Heart Fail Rev       Date:  2006-12       Impact factor: 4.214

4.  Left ventricular mass-geometry and silent cerebrovascular disease: The Cardiovascular Abnormalities and Brain Lesions (CABL) study.

Authors:  Koki Nakanishi; Zhezhen Jin; Shunichi Homma; Mitchell S V Elkind; Tatjana Rundek; Aylin Tugcu; Mitsuhiro Yoshita; Charles DeCarli; Clinton B Wright; Ralph L Sacco; Marco R Di Tullio
Journal:  Am Heart J       Date:  2016-12-21       Impact factor: 4.749

5.  Association of growth differentiation factor 11/8, putative anti-ageing factor, with cardiovascular outcomes and overall mortality in humans: analysis of the Heart and Soul and HUNT3 cohorts.

Authors:  Kristoff A Olson; Alexis L Beatty; Bettina Heidecker; Mathilda C Regan; Edward N Brody; Trudi Foreman; Shintaro Kato; Robert E Mehler; Britta S Singer; Kristian Hveem; Havard Dalen; David G Sterling; Richard M Lawn; Nelson B Schiller; Stephen A Williams; Mary A Whooley; Peter Ganz
Journal:  Eur Heart J       Date:  2015-08-20       Impact factor: 29.983

6.  Echocardiographic left ventricular mass index predicts incident stroke in African Americans: Atherosclerosis Risk in Communities (ARIC) Study.

Authors:  Ervin R Fox; Nabhan Alnabhan; Alan D Penman; Kenneth R Butler; Herman A Taylor; Thomas N Skelton; Thomas H Mosley
Journal:  Stroke       Date:  2007-08-30       Impact factor: 7.914

7.  Left ventricular global function index by magnetic resonance imaging--a novel marker for assessment of cardiac performance for the prediction of cardiovascular events: the multi-ethnic study of atherosclerosis.

Authors:  Nathan Mewton; Anders Opdahl; Eui-Young Choi; Andre L C Almeida; Nadine Kawel; Colin O Wu; Gregory L Burke; Songtao Liu; Kiang Liu; David A Bluemke; Joao A C Lima
Journal:  Hypertension       Date:  2013-02-19       Impact factor: 10.190

8.  Relation between long sleep and left ventricular mass (from a multiethnic elderly cohort).

Authors:  Alberto R Ramos; Zhezhen Jin; Tatjana Rundek; Cesare Russo; Shunichi Homma; Mitchell S V Elkind; Ralph L Sacco; Marco R Di Tullio
Journal:  Am J Cardiol       Date:  2013-05-24       Impact factor: 2.778

9.  Novel quantitative trait locus is mapped to chromosome 12p11 for left ventricular mass in Dominican families: the Family Study of Stroke Risk and Carotid Atherosclerosis.

Authors:  Liyong Wang; Ashley Beecham; Marco R Di Tullio; Susan Slifer; Susan H Blanton; Tatjana Rundek; Ralph L Sacco
Journal:  BMC Med Genet       Date:  2009-07-23       Impact factor: 2.103

Review 10.  A combined role of calcium channel blockers and angiotensin receptor blockers in stroke prevention.

Authors:  Ji-Guang Wang
Journal:  Vasc Health Risk Manag       Date:  2009-08-06
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.